Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kiniksa Pharmaceuticals, Ltd. (KNSA)  
$38.64 0.28 (0.72%) as of 4:30 Fri 10/17


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 40,450,000
Market Cap: 1.56(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.17 - $38.92
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Kiniksa Pharmaceuticals is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with unmet medical need. Co.'s portfolio of assets include: ARCALYST® (rilonacept) is for the treatment of Cryopyrin-Associated Periodic Syndrome; mavrilimumab is targeting granulocyte-macrophage colony stimulating factor receptor alpha; vixarelimab is evaluating vixarelimab for the potential treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404 is a humanized monoclonal antibody that is designed to inhibit the CD40-CD154 interaction.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 596,839 1,125,936 1,395,801 1,954,267
Total Sell Value $20,358,389 $34,918,412 $40,792,500 $54,172,778
Total People Sold 6 8 8 8
Total Sell Transactions 16 46 63 83
End Date 2025-07-20 2025-04-18 2024-10-18 2023-10-19

   
Records found: 496
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-10-14 4 AS $37.65 $465,843 D/D (12,368) 28,684 2%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-10-14 4 OE $8.83 $57,395 D/D 6,500 41,052     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-10-04 4 D $38.49 $3,272 D/D (85) 38,101     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-10-04 4 OE $0.00 $0 D/D 175 38,186     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-29 4 AS $38.33 $1,609,860 D/D (42,000) 34,552 -0%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-29 4 OE $17.92 $752,640 D/D 42,000 76,552     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-15 4 AS $36.45 $597,976 D/D (16,400) 34,552 6%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-15 4 OE $8.83 $57,395 D/D 6,500 50,952     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-05 4 AS $35.66 $477,452 D/D (13,389) 44,452 8%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-05 4 OE $15.52 $207,797 D/D 13,389 57,841     -
   Moat Ross CHIEF CORP. & COMM. OFFICER   •       –      –    2025-09-04 4 AS $35.31 $124,397 D/D (3,523) 9,415 9%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-04 4 AS $35.52 $3,028,826 D/D (85,271) 44,452 9%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-04 4 OE $15.50 $1,322,631 D/D 85,271 129,723     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-03 4 AS $35.50 $535,731 D/D (15,091) 44,452 9%     
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-03 4 OE $15.50 $233,912 D/D 15,091 59,543     -
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-09-03 4 AS $34.84 $383,240 D/D (11,000) 38,011 9%     
   Megna Michael R CHIEF ACCOUNTING OFFICER   •       –      –    2025-09-03 4 OE $17.92 $197,120 D/D 11,000 49,011     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-02 4 D $34.28 $32,566 D/D (950) 44,452     -
   Tessari Eben CHIEF OPERATING OFFICER   •       –      –    2025-09-02 4 OE $0.00 $0 D/D 1,964 45,402     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-09-02 4 D $34.28 $108,908 D/D (3,177) 111,794     -
   Patel Sanj K CHAIRMAN & CEO   •       •      –    2025-09-02 4 OE $0.00 $0 D/D 6,569 114,971     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-09-02 4 D $34.28 $30,852 D/D (900) 31,086     -
   Ragosa Mark CHIEF FINANCIAL OFFICER   •       –      –    2025-09-02 4 OE $0.00 $0 D/D 1,861 31,986     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2025-09-02 4 D $34.28 $28,624 D/D (835) 61,324     -
   Paolini John F. CHIEF MEDICAL OFFICER   •       –      –    2025-09-02 4 OE $0.00 $0 D/D 1,725 62,159     -
  496 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us